BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17192792)

  • 1. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
    Wang X; Jones TD; Zhang S; Eble JN; Bostwick DG; Qian J; Lopez-Beltran A; Montironi R; Harris JJ; Cheng L
    Mod Pathol; 2007 Feb; 20(2):175-82. PubMed ID: 17192792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.
    Kersting C; Kuijper A; Schmidt H; Packeisen J; Liedtke C; Tidow N; Gustmann C; Hinrichs B; Wülfing P; Tio J; Boecker W; van Diest P; Brandt B; Buerger H
    Lab Invest; 2006 Jan; 86(1):54-61. PubMed ID: 16258523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma.
    Sawada M; Tsuda H; Kimura M; Okamoto S; Kita T; Kasamatsu T; Yamada T; Kikuchi Y; Honjo H; Matsubara O
    Cancer Sci; 2003 Nov; 94(11):986-91. PubMed ID: 14611676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy.
    Gilbert JA; Goetz MP; Reynolds CA; Ingle JN; Giordano KF; Suman VJ; Blair HE; Jenkins RB; Lingle WL; Reinholz MM; Adjei AA; Ames MM
    Mol Cancer Ther; 2008 Apr; 7(4):944-51. PubMed ID: 18413808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
    Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
    Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L
    Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.
    Williams MD; Roberts DB; Kies MS; Mao L; Weber RS; El-Naggar AK
    Clin Cancer Res; 2010 Apr; 16(8):2266-74. PubMed ID: 20371674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR.
    Simper NB; Jones CL; MacLennan GT; Montironi R; Williamson SR; Osunkoya AO; Wang M; Zhang S; Grignon DJ; Eble JN; Tran T; Wang L; Baldrige LA; Cheng L
    Hum Pathol; 2015 Jun; 46(6):805-12. PubMed ID: 25870120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Egfr amplification specific gene expression in phyllodes tumours of the breast.
    Agelopoulos K; Kersting C; Korsching E; Schmidt H; Kuijper A; August C; Wülfing P; Tio J; Boecker W; van Diest PJ; Brandt B; Buerger H
    Cell Oncol; 2007; 29(6):443-51. PubMed ID: 18032821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
    Djordjevic B; Hanna WM
    Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Her-2-neu expression and progression toward androgen independence in human prostate cancer.
    Signoretti S; Montironi R; Manola J; Altimari A; Tam C; Bubley G; Balk S; Thomas G; Kaplan I; Hlatky L; Hahnfeldt P; Kantoff P; Loda M
    J Natl Cancer Inst; 2000 Dec; 92(23):1918-25. PubMed ID: 11106683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR and gastrointestinal stromal tumor: an immunohistochemical and FISH study of 82 cases.
    Lopes LF; Bacchi CE
    Mod Pathol; 2007 Sep; 20(9):990-4. PubMed ID: 17643098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Kit expression and mutations in phyllodes tumors of the breast.
    Bose P; Dunn ST; Yang J; Allen R; El-Khoury C; Tfayli A
    Anticancer Res; 2010 Nov; 30(11):4731-6. PubMed ID: 21115932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.
    Tse GM; Lui PC; Vong JS; Lau KM; Putti TC; Karim R; Scolyer RA; Lee CS; Yu AM; Ng DC; Tse AK; Tan PH
    Breast Cancer Res Treat; 2009 Apr; 114(3):441-8. PubMed ID: 18443904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of EGFR, HER-2/neu and KIT in germ cell tumours.
    Durán I; García-Velasco A; Ballestín C; García E; Martínez-Tello F; Pond GR; García-Carbonero R; Cortés-Funés H; Paz-Ares L
    Clin Transl Oncol; 2010 Jun; 12(6):443-9. PubMed ID: 20534400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.
    Ross JS; Sheehan C; Hayner-Buchan AM; Ambros RA; Kallakury BV; Kaufman R; Fisher HA; Muraca PJ
    Hum Pathol; 1997 Jul; 28(7):827-33. PubMed ID: 9224752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast.
    Vranic S; Tawfik O; Palazzo J; Bilalovic N; Eyzaguirre E; Lee LM; Adegboyega P; Hagenkord J; Gatalica Z
    Mod Pathol; 2010 May; 23(5):644-53. PubMed ID: 20208479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
    Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
    Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.